{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:05:19Z","timestamp":1778198719187,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Agricultural Products Utilization Committee"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.06.030","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T12:51:27Z","timestamp":1561121487000},"page":"4291-4301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs"],"prefix":"10.1016","volume":"37","author":[{"given":"Gagandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Zholobko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Pillatzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriy","family":"Voronov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5906-5974","authenticated-orcid":false,"given":"Sheela","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.030_b0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.coviro.2012.03.003","article-title":"The role of receptor binding specificity in interspecies transmission of influenza viruses","volume":"2","author":"Imai","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1863-2378.2008.01217.x","article-title":"The role of swine in the generation of novel influenza viruses","volume":"56","author":"Ma","year":"2009","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2019.06.030_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.06.030_b0020","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0035","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.micinf.2010.01.001","article-title":"Research and development of universal influenza vaccines","volume":"12","author":"Du","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.06.030_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2019.06.030_b0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4142\/jvs.2016.17.1.71","article-title":"A novel M2e-multiple antigenic peptide providing heterologous protection in mice","volume":"17","author":"Wen","year":"2016","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2019.06.030_b0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/vim.2015.0050","article-title":"Protective immunity against homologous and heterologous influenza virus lethal challenge by immunization with new recombinant chimeric HA2-M2e fusion protein in BALB\/C mice","volume":"29","author":"Ameghi","year":"2016","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygeno.2012.06.003","article-title":"Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets","volume":"100","author":"Wu","year":"2012","journal-title":"Genomics"},{"key":"10.1016\/j.vaccine.2019.06.030_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1743-422X-7-351","article-title":"Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development","volume":"7","author":"Stanekov\u00e1","year":"2010","journal-title":"Virology J"},{"key":"10.1016\/j.vaccine.2019.06.030_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191739","article-title":"Comparison of the efficacy of a commercial inactivated influenza A\/H1N1\/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model","volume":"13","author":"Opriessnig","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.030_b0075","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1099\/0022-1317-83-8-1851","article-title":"Vaccination of pigs with a DNA construct expressing an influenza virus M2\u2013nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus","volume":"83","author":"Heinen","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0080","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","article-title":"Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins","volume":"26","author":"Chun","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(85)90157-6","article-title":"Fusion mutants of the influenza virus hemagglutinin glycoprotein","volume":"40","author":"Daniels","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.06.030_b0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/av_2011_01_61","article-title":"Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein","volume":"55","author":"Stanekova","year":"2011","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0095","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.06.030_b0100","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3390\/v6083159","article-title":"Options and obstacles for designing a universal influenza vaccine","volume":"6","author":"Jang","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.06.030_b0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2019.06.030_b0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0167-7799(00)01485-2","article-title":"Poloxamers and poloxamines in nanoparticle engineering and experimental medicine","volume":"18","author":"Moghimi","year":"2000","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0115","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/js980072c","article-title":"Design and development of adjuvant-active nonionic block copolymers","volume":"87","author":"Newman","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2019.06.030_b0120","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.vaccine.2007.01.120","article-title":"Chemical adjuvants for plasmid DNA vaccines","volume":"25","author":"Greenland","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.actbio.2014.11.050","article-title":"Effective polymer adjuvants for sustained delivery of protein subunit vaccines","volume":"14","author":"Adams","year":"2015","journal-title":"Acta Biomater"},{"key":"10.1016\/j.vaccine.2019.06.030_b0130","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/la052225z","article-title":"Invertible architectures from amphiphilic polyesters","volume":"22","author":"Voronov","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.vaccine.2019.06.030_b0135","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1021\/la801769v","article-title":"Mechanism of silver ion reduction in concentrated solutions of amphiphilic invertible polyesters in nonpolar solvent at room temperature","volume":"24","author":"Voronov","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.vaccine.2019.06.030_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/macp.201700344","article-title":"1H NMR Study of \u201chost\u2013guest\u201d interactions of micellar assemblies from amphiphilic invertible polymers and peptides","volume":"218","author":"Kohut","year":"2017","journal-title":"Macromol Chem Phys"},{"key":"10.1016\/j.vaccine.2019.06.030_b0145","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jpcc.8b09206","article-title":"Inversion of polymeric micelles probed by spin labeled peptide incorporation and electron paramagnetic resonance","author":"Pan","year":"2018","journal-title":"J Phys Chem C"},{"key":"10.1016\/j.vaccine.2019.06.030_b0150","unstructured":"Organization WH. Manual for the laboratory diagnosis and virological surveillance of influenza; 2011."},{"key":"10.1016\/j.vaccine.2019.06.030_b0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints 1 2","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0160","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.06.030_b0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2010.11.030","article-title":"Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus","volume":"403","author":"Hashem","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2019.06.030_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-3083.1994.tb03464.x","article-title":"The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection","volume":"40","author":"Nagy","year":"1994","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-2478(97)00137-5","article-title":"A hemagglutinin-based multipeptide construct elicits enhanced protective immune response in mice against influenza A virus infection","volume":"60","author":"Horv\u00e1th","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2019.06.030_b0180","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1039\/c1py00399b","article-title":"Interfacial micellar phase transfer using amphiphilic invertible polymers","volume":"2","author":"Hevus","year":"2011","journal-title":"Polym Chem"},{"key":"10.1016\/j.vaccine.2019.06.030_b0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2019.06.030_b0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetmic.2009.09.056","article-title":"Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination","volume":"142","author":"Opriessnig","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0195","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/030098589503200606","article-title":"Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus","volume":"32","author":"Halbur","year":"1995","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0200","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A\/H1N1 influenza virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0205","first-page":"44","article-title":"Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome","volume":"39","author":"Ellis","year":"1998","journal-title":"Canad Veterin J = La revue veterinaire canadienne"},{"key":"10.1016\/j.vaccine.2019.06.030_b0210","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.vaccine.2009.02.011","article-title":"A universal epitope-based influenza vaccine and its efficacy against H5N1","volume":"27","author":"Adar","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0215","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-3-102","article-title":"Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2","volume":"3","author":"Feng","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2019.06.030_b0225","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.06.030_b0230","doi-asserted-by":"crossref","first-page":"e00018","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2019.06.030_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2019.06.030_b0240","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000319440","article-title":"Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens","volume":"54","author":"Zhang","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2019.06.030_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/316926","article-title":"A novel lactococcal vaccine expressing a peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza a virus prolongs survival of vaccinated chickens","volume":"2013","author":"Reese","year":"2013","journal-title":"Veterin Med Int"},{"key":"10.1016\/j.vaccine.2019.06.030_b0255","doi-asserted-by":"crossref","first-page":"P62","DOI":"10.1186\/1753-6561-5-S1-P62","article-title":"Antibody-Dependent Enhancement (ADE) of infection and its possible role in the pathogenesis of influenza","author":"Dutry","year":"2011","journal-title":"BMC Proc"},{"key":"10.1016\/j.vaccine.2019.06.030_b0260","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-4-118","article-title":"Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse","volume":"4","author":"Mozdzanowska","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2019.06.030_b0265","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.vaccine.2018.06.051","article-title":"Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen","volume":"36","author":"Price","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.030_b0270","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2018.03.024","article-title":"Vaccine options for influenza: thinking small","volume":"53","author":"Schepens","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0275","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3389\/fimmu.2017.01730","article-title":"Cross-protective efficacy of influenza virus M2e containing virus-like particles is superior to hemagglutinin vaccines and variable depending on the genetic backgrounds of mice","volume":"8","author":"Kim","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.06.030_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028445","article-title":"Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice","volume":"6","author":"Wolf","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.06.030_b0285","doi-asserted-by":"crossref","first-page":"20120536","DOI":"10.1098\/rsif.2012.0536","article-title":"Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases","volume":"10","author":"Shakya","year":"2013","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2019.06.030_b0290","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1021\/bm3007924","article-title":"Invertible micellar polymer assemblies for delivery of poorly water-soluble drugs","volume":"13","author":"Hevus","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.vaccine.2019.06.030_b0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-1702(97)00143-3","article-title":"Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin","volume":"53","author":"Imai","year":"1998","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:29Z","timestamp":1759401209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":59,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19307923"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}